Quality improvement and research for high-risk newborns in Switzerland
Swiss Neonatal Network & Follow-up Group
This study is trying to improve the care and safety of high-risk newborns in Switzerland by collecting and sharing information from different hospitals to help doctors do a better job.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 0 Days to 28 Days |
| Sex | All |
| Sponsor | Swiss Neonatal Network Research network |
| Locations | 1 site (Zurich) |
| Trial ID | NCT04239508 on ClinicalTrials.gov |
What this trial studies
The Swiss Neonatal Network & Follow-Up Group aims to enhance the quality and safety of medical care for high-risk newborn infants and their families in Switzerland. This observational initiative collects and monitors data from various neonatal units to assess care outcomes and improve practices through collaborative audits and research. The network also facilitates educational meetings and releases annual quality reports to participating centers, focusing on process and outcome indicators. Additionally, it supports local researchers in conducting studies on mortality, morbidity, and long-term outcomes using the collected data.
Who should consider this trial
Good fit: Ideal candidates for this initiative include Swiss live-born infants below 32 weeks gestational age or weighing less than 1501g at birth.
Not a fit: Patients who are not live-born or do not meet the specified gestational age and weight criteria may not benefit from this initiative.
Why it matters
Potential benefit: If successful, this initiative could lead to improved health outcomes and care quality for high-risk newborns in Switzerland.
How similar studies have performed: Other similar initiatives have shown success in improving neonatal care quality, making this approach both relevant and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria of "Minimal Neonatal Dataset" (MNDS): All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight Inclusion criteria of "Below 34 data collection", (B34): All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight Inclusion criteria of "Swiss Asphyxia and Cooling Registry", (ASP): Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia
Where this trial is running
Zurich
- Department of Neonatology — Zurich, Switzerland (Recruiting)
Study contacts
- Study coordinator: Mark Adams, PhD
- Email: mark.adams@usz.ch
- Phone: +41432533034
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.